Standard Biotools Inc
(LAB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2010 | 06-2010 | 03-2010 | 12-2009 | 09-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -13,824 | -10,444 | -5,625 | -38,823 | -15,700 |
| Depreciation Amortization | 1,164 | 818 | 405 | 4,784 | 1,509 |
| Income taxes - deferred | N/A | N/A | N/A | -31,756 | N/A |
| Accounts receivable | 1,511 | 2,117 | 1,470 | N/A | -3,057 |
| Accounts payable and accrued liabilities | -419 | -384 | 278 | N/A | -701 |
| Other Working Capital | 2,419 | 3,025 | 2,115 | -40,367 | -1,221 |
| Other Operating Activity | -98 | -1,159 | -1,596 | 22,756 | 4,782 |
| Operating Cash Flow | $-9,247 | $-6,027 | $-2,953 | $-83,406 | $-14,388 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,130 | -658 | -359 | -2,539 | -610 |
| Other Investing Activity | 131 | 131 | 0 | 0 | 0 |
| Investing Cash Flow | $-999 | $-527 | $-359 | $-2,539 | $-610 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | 0 | N/A | N/A | 10,510 |
| Debt Repayment | 0 | 0 | -455 | N/A | -1,034 |
| Common Stock Issued | 31 | 11 | N/A | N/A | 53 |
| Common Stock Repurchased | N/A | N/A | N/A | -25,200 | N/A |
| Other Financing Activity | 633 | 0 | 0 | -9,100 | 0 |
| Financing Cash Flow | $664 | $11 | $-455 | $-34,300 | $9,529 |
| Exchange Rate Effect | 63 | N/A | -2 | 2,803 | 48 |
| Beginning Cash Position | 14,602 | 14,602 | 14,602 | 304,179 | 17,796 |
| End Cash Position | 5,083 | 8,069 | 10,833 | 186,737 | 12,375 |
| Net Cash Flow | $-9,519 | $-6,533 | $-3,769 | $-117,442 | $-5,421 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,247 | -6,027 | -2,953 | -83,406 | -14,388 |
| Capital Expenditure | -1,130 | -658 | -359 | -2,539 | -646 |
| Free Cash Flow | -10,377 | -6,685 | -3,312 | -85,945 | -15,034 |